Support
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.

SELECTED REFERENCES

Published articles using tissue microarrays from US Biomax:

  1. Promising Noninvasive Cellular Phenotype in Prostate Cancer Cells Knockdown of Matrix Metalloproteinase 9. Aditi Gupta, Wei Cao, Kavitha Sadashivaiah, Wantao Chen, Abraham Schneider and Meenakshi A. Chellaiah. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells. 2013 2013:13. (Product used TMA PR242, PR481 and PR956). (link)
  2. Coordinate Autophagy and mTOR Pathway Inhibition Enhances Cell Death in Melanoma. Xiaoqi Xie, Eileen P. White, Janice M. Mehnert. PLoS ONE. 2013 8(1):e55096. (Product used TMA Melanoma). (link)
  3. Tumor Suppressor MicroRNA-493 Decreases Cell Motility and Migration Ability in Human Bladder Cancer Cells by Downregulating RhoC and FZD4. Koji Ueno, Hiroshi Hirata, Shahana Majid, Soichiro Yamamura, Varahram Shahryari, Z. Laura Tabatabai, Yuji Hinoda and Rajvir Dahiya. Mol Cancer. 2013 11:244. (Product used TMA BL801). (link)
  4. ICAD Deficiency in Human Colon Cancer and Predisposition to Colon Tumorigenesis: Linkage to Apoptosis Resistance and Genomic Instability. Youssef Errami, Hassan Brim, Karine Oumouna-Benachour, Mustapha Oumouna, Amarjit S. Naura, Hogyoung Kim, Jihang Ju, Christian J. Davis, Jong G. Kim, Hassan Ashktorab, Kenneth Fallon, Ming Xu and Jianhua Zhang. PLoS ONE. 2013 8(2):e57871. (Product used TMA BC0015). (link)
  5. Lack of Increased P15 INK4B Protein Expression in Basal Cell Carcinomas. Ahmed Ismail Hassan Moad, Mei Lan Tan, Gurjeet Kaur and Mohamed Mabruk. Asian Pacific J Cancer Pre. 2013 13(12):6239-6244. (Product used TMA Cell). (link)
  6. Hornerin, an S100 family protein, is functional in breast cells and aberrantly expressed in breast cancer. Jodie M Fleming, Erika Ginsburg, Shannon D Oliver, Paul Goldsmith and Barbara K Vonderhaar. BMC Cancer. 2013 12:266. (Product used TMA BR2085a, BR805). (link)
  7. Reciprocal Regulation of Annexin A2 and EGFR with Her-2 in Her-2 Negative and Herceptin-Resistant Breast Cancer. Praveenkumar K. Shetty, Sanjay I. Thamake, Swati Biswas, Sonny L. Johansson and Jamboor K. Vishwanatha. PLoS One. 2013 7(9):e44299. (Product used TMA Breast). (link)
  8. MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma. E Sonkoly, J Loven, N Xu, F Meisgen, T Wei, P Brodin, V Jaks, M Kasper, T Shimokawa, M Harada, J Heilborn, M-A Hedblad, A Hippe, D Grander, B Homey, P G Zaphiropoulos, M Arsenian-Henriksson, M Sthle and A Pivarcsi. Oncogenesis. 2013 1:e3. (Product used TMA Cell). (link)
  9. Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer. Venkatakrishna Rao Jala, Brandie N Radde, Bodduluri Haribabu and Carolyn M Klinge. BMC Cancer. 2013 12:624. (Product used TMA LC242, LC1005 ). (link)
  10. HGF and c-Met Interaction Promotes Migration in Human Chondrosarcoma Cells. Hsi-Kai Tsou, Hsien-Te Chen, Ya-Huey Hung, Chia-Hao Chang, Te-Mao L, Yi-Chin Fong and Chih-Hsin Tang. PLoS One. 2013 8(1):e53974. (Product used TMA Cells). (link)
  11. RNA-binding protein AUF1 represses Dicer expression. Kotb Abdelmohsen, Kumiko Tominaga-Yamanaka, Subramanya Srikantan, Je-Hyun Yoon, Min-Ju Kang and Myriam Gorospe. Nucl. Acids Res. 2013 10:1093. (Product used TMA ). (link)
  12. uPAR and cathepsin B shRNA impedes TGF-B1-driven proliferation and invasion of meningioma cells in a XIAP-dependent pathway. V R Gogineni, R Gupta, A K Nalla, K K Velpula and J S Rao. Cell death and Disease. 2013 3:e439. (Product used TMA Meningioma). (link)
  13. Tissue Microarray Cytometry Reveals Positive Impact of Homeodomain Interacting Protein Kinase 2 in Colon Cancer Survival Irrespective of p53 Function. Isabelle Soubeyran, Isabelle Mahouche, Aude Grigoletto, Thierry Leste-Lasserre, Guillaume Drute, Christophe Rey, Stephane Pedeboscq, France Blanchard, Veronique Brouste, Jean-Christophe Sabourin, Yves Becouarn, Josy Reiffers, Franqois Ichas and Francesca De Giorgi. Am J Pathol. 2013 178(5):1986-1998. (Product used TMA CO951). (link)
  14. The double immunostaining of CD133 and Ki-67 favours a significant co-localization pattern in fibroblastic subtype of meningiomas. Baki S. Albayrak, Ozgur Ismailoglu, Gamze Tanriover, Eralp N. Cetinalp, Necdet Demir. Neurologia i Neurochirurgia Polska. 2013 45(5):467-473. (Product used TMA MG801). (link)
  15. A Role of Sphingosine Kinase 1 in head & neck carcinogenesis. Keisuke Shirai, Tatsuya Kaneshiro, Masayuki Wada, Hideki Furuya, Jacek Bielawski, Yusuf A. Hannun, Lina M. Obeid, Besim Ogretmen and Toshihiko Kawamori. Cancer Prev Res (Phila). 2013 4(3):454-462. (Product used TMA HN811, HN803). (link)
  16. The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors. Eva Sigstad, Elisabeth Paus, Trine Bjoro, Aasmund Berner, Krystyna Kotanska Grholt, Lars H Jrgensen, Manuel Sobrinho-Simes, Ruth Holm and David J Warren. Mod Pathol. 2013 25(4):537-547. (Product used TMA TH802). (link)
  17. Inactivation of androgen-induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis. Zehua Wanga, Zemin Wanga, Jianhui Guoa, Yingchun Lia, Jasmin H. Bavarvaa, Chiping Qiana, M. Christiane Brahimi-Hornc, Deyong Tanb and Wanguo Liua, . PNAS. 2013 109:3053-3058. (Product used TMA Prostate). (link)
  18. Orexin 2 receptor as a potential target for immunotoxin and antibody-drug conjugate cancer therapy. MASATO KISHIDA, KAZUNORI ISHIGE, TOMOHISA HORIBE, NORIKO TADA, NOBUTAKA KOIBUCHI, JUNICHI SHODA, KIYOSHI KITA and KOJI KAWAKAMI. Oncol Lett. 2013 3(3):525-529. (Product used TMA Cancer). (link)
  19. CD138 (Syndecan-1) Expression in Bone-Forming Tumors. Amberly L. Nunez, MD, Gene P. Siegal, MD, PhD, Vishnu V.B. Reddy, MD and Shi Wei, MD, PhD. American Journal of Clinical Pathology. 2013 137:423-428. (Product used TMA Bone). (link)
  20. Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism. Alexandre Cassagoa, Amanda P. S. Ferreiraa, Igor M. Ferreiraa, Camila Fornezaria, Emerson R. M. Gomesa, Kai Su Greeneb, Humberto M. Pereirac, Richard C. Garrattc, Sandra M. G. Diasa and Andre L. B. Ambrosioa. PNAS. 2013 109(4):1092-1097. (Product used TMA Cancer). (link)
  21. Inhibition of Fatty Acid Synthase Attenuates CD44-Associated Signaling and Reduces Metastasis in Colorectal Cancer. Yekaterina Y. Zaytseva, Piotr G. Rychahou, Pat Gulhati, Victoria A. Elliott, William C. Mustain, Kathleen O'Connor, Andrew J. Morris, Manjula Sunkara, Heidi L. Weiss, Eun Y. Lee and B. Mark Evers. . 2013 :. (Product used TMA CO702). (link)
  22. Fluorescence In Situ Hybridization for MicroRNA Detection in Archived Oral Cancer Tissues. Zonggao Shi, Jeffrey J. Johnson and M. Sharon Stack. Journal of Oncology. 2012 903581:8. (Product used TMA Oral Cancer). (link)
  23. Pigment Epithelium-Derived Factor Is an Intrinsic Antifibrosis Factor Targeting Hepatic Stellate Cells. Tsung-Chuan Ho, Show-Li Chen, Shou-Chuan Shih, Ju-Yun Wu, Wen-Hua Han, Huey-Chuan Cheng, Su-Lin Yang and Yeou-Ping Tsao. Am J Pathol. 2012 177(4):1798-1811. (Product used TMA LV805). (link)
  24. ELEVATED EXPRESSION OF CXC CHEMOKINES IN PEDIATRIC OSTEOSARCOMA PATIENTS. Yiting Li, MD, PhD, Ricardo Flores, MD, Alexander Yu, BSc, M. Fatih Okcu, MD, Jeffrey Murray, MD, Murali Chintagumpala, MD, John Hicks, MD, Ching C. Lau, MD, PhD, and Tsz-Kwong Man, PhD. Cancer. 2012 117(1):207-217. (Product used TMA ). (link)
  25. P21-activated protein kinase (PAK2)-mediated c-Jun phosphorylation at 5 threonine sites promotes cell transformation. Tingting Li, Jishuai Zhang, Feng Zhu, Weihong Wen, Tatyana Zykova, Xiang Li, Kangdong Liu, Cong Peng, Weiya Ma, Guozheng Shi, Ziming Dong, Ann M. Bode and Zigang Dong. Carcinogenesis. 2012 32(5):659-666. (Product used TMA ). (link)
  26. Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1. Yu Deng, Jing Liu, Gangwen Han, Shi-Long Lu, Su-Yan Wang, Stephen Malkoski, Aik Choon Tan, Chuxia Deng, Xiao-Jing Wang and Qinghong Zhang. Oncogene. 2012 29(50):6603-6608. (Product used TMA HN801). (link)
  27. Eph/Ephrin Profiling in Human Breast Cancer Reveals Significant Associations between Expression Level and Clinical Outcome. Dana M. Brantley-Sieders, Aixiang Jiang, Krishna Sarma, Akosua Badu-Nkansah, Debra L. Walter, Yu Shyr and Jin Chen . PLoS ONE. 2012 6(9):e24426. (Product used TMA BR480). (link)
  28. The First Type III Domain of Fibronectin is Associated with the Expression of Cytokines within the Lung Tumor Microenvironment. Mingzhe Zheng, David M. Jones, Carol Horzempa, Aparna Prasad and Paula J. McKeown-Longo. J Cancer. 2012 2:478-483. (Product used TMA Lung ). (link)
  29. Factors Influencing the Degradation of Archival Formalin-Fixed Paraffin-Embedded Tissue Sections. Ran Xie, Joon-Yong Chung, Kris Ylaya, Reginald L. Williams, Natalie Guerrero, Nathan Nakatsuka, Cortessia Badie, Stephen M. Hewitt. J Histochem Cytochem. 2012 59(4):356-365. (Product used TMA ). (link)
  30. Beta-Catenin Phosphorylated at Threonine 120 Antagonizes Generation of Active Beta-Catenin by Spatial Localization in trans-Golgi Network. Cheng Du, Chuanyou Zhang, Zhuo Li, Md. Helal Uddin Biswas and K. C. Balaji. PLoS ONE. 2012 7(4):e33830. (Product used TMA ). (link)
  31. Modulation of STAT3 activation and prostate cancer proliferation by cyclin-dependent kinase 5 . Fu-Ning Hsu, Ming-Ching Chiang, Eugene Lin and Ho Lin. CA Cancer J Clin. 2012 60:277-300. (Product used TMA Prostate). (link)
  32. Engrailed-2 (EN2): A Tumor Specific Urinary Biomarker for the Early Diagnosis of Prostate Cancer. . Clin Cancer Res March. 2012 17:1090-1098. (Product used TMA PR2085a). (link)
  33. LPA Receptor Heterodimerizes with CD97 to Amplify LPA-Initiated RHO-Dependent Signaling and Invasion in Prostate Cancer Cells. Yvona Ward, Ross Lake and Juan Juan Yin. Cancer Res . 2012 71:7301-7311. (Product used TMA Prostate Cancer). (link)
  34. Novel Strategy for Selection of Monoclonal Antibodies Against Highly Conserved Antigens: Phage Library Panning Against Ephrin-B2 Displayed on Yeast. Xiaoling Gu equal contributor, Yogindra Vedvyas equal contributor, Xiaoyue Chen equal contributor, Tanwi Kaushik, Chang-Il Hwang, Xuebo Hu, Alexander Y. Nikitin and Moonsoo M. Jin. PLoS ONE. 2012 7(1):e30680. (Product used TMA TP484). (link)
  35. Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study. Su Y, Zheng Y, Zheng W, Gu K, Chen Z, Li G, Cai Q, Lu W, Shu XO. BMC Cancer. 2012 :. (Product used TMA BR701). (link)
  36. MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer. Hiroshi Hirata, Yuji Hinoda, Koji Ueno, Varahram Shahryari, Z. Laura Tabatabai and Rajvir Dahiya. . 2012 :. (Product used TMA BL801). (link)
  37. p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6. Sameer Phalke, Slim Mzoughi, Marco Bezzi, Nancy Jennifer, Wei Chuen Mok, Diana H. P. Low, Aye Aye Thike, Vladimir A. Kuznetsov, Puay Hoon Tan4, P. Mathijs Voorhoeve and Ernesto Guccione. Nucl. Acids Res.. 2012 10:1093. (Product used TMA BR2001, BR802 ). (link)
  38. The Desmosomal Armadillo Protein Plakoglobin Regulates Prostate Cancer Cell Adhesion and Motility through Vitronectin-Dependent Src Signaling. Carrie A. Franzen, Viktor Todorovi, Bhushan V. Desai, Salida Mirzoeva, Ximing J. Yang, Kathleen J. Green, Jill C. Pelling. plosone. 2012 :. (Product used TMA BC19021). (link)
  39. Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients. Xiangshan Zhao, Sameer Mirza, Alaa Alshareeda, Ying Zhang,Channabasavaiah Basavaraju Gurumurthy, Aditya Bele, Jun Hyun Kim, Shakur Mohibi,Monica Goswami, Subodh M. Lele, William West, Fang Qiu, Ian O. Ellis, Emad A. Rakha, Andrew R. Green, Hamid Band and Vimla Band. Breast Cancer Res Treat. 2012 134(1):171-180. (Product used TMA Breast). (link)
  40. PEA-15 unphosphorylated at both serine 104 and serine 116 inhibits ovarian cancer cell tumorigenicity and progression through blocking catenin. J Lee1, C Bartholomeusz, S Krishnamurthy, P Liu, H Saso, T A LaFortune, G N Hortobagyi and N T Ueno. Tumour suppression. 2012 10:1038. (Product used TMA Ovarian ). (link)
  41. Involvement of CCR6/CCL20/IL-17 Axis in NSCLC Disease Progression. PLoS One. PLoS One. 2011 6(9):e24856. (Product used TMA BC041115). (link)
  42. Epac1 promotes melanoma metastasis via modification of heparan sulfate. Erdene Baljinnyam, masanari Umemura, mariana s. de lorenzo, mizuka iwatsubo,suzie Chen, James s. goydos and Kousaku iwatsubo. PIgMent Cell & MelAnoMA Research. 2011 24(4):680-687. (Product used TMA ME2082). (link)
  43. Expression of Aryl Hydrocarbon Receptor in Human Placentas and Fetal Tissues. Yi-zhou Jiang,Kai Wang,Roy Fang and Jing Zheng . J Histochem Cytochem . 2011 58(8):679-685 . (Product used TMA BE01015). (link)
  44. CXCR7 Protein Expression in Human Adult Brain and Differentiated Neurons. Saori Shimiz, Michael Brown, Rajarshi Sengupta, Mark E. Penfold and Olimpia Meucci. journal.pone. 2011 6(5):10.1371. (Product used TMA BR721). (link)
  45. Immunolocalization of Phostensin in Lymphatic Cells and Tissues. Yu-Shan Lin,Kuang-Yung Huang,Tzu-Fan Wang,Hsien-lu Huang,Hui-Chun Yu,Jia-yi Yen,Shih-hui Hung,Su-Qin Liu,Ning-Sheng Lai and Hsien-bin Huang. J Histochem Cytochem. 2011 59(8):741-749. (Product used TMA LN801). (link)
  46. Knockdown of MTDH Sensitizes Endometrial Cancer Cells to Cell Death Induction by Death Receptor Ligand TRAIL and HDAC Inhibitor LBH589 Co-Treatment. Xiangbing Meng, Pavla Brachova, Shujie Yang, Zhi Xiong, Yuping Zhang, Kristina W. Thiel and Kimberly K. Leslie. journal.pone. 2011 6(6):10.1371. (Product used TMA UT801). (link)
  47. Myc Promoter-Binding Protein-1 (MBP-1) Is a Novel Potential Prognostic Marker in Invasive Ductal Breast Carcinoma. Mariavera Lo Presti1, Arianna Ferro1, Flavia Contino, Claudia Mazzarella, Silvia Sbacchi, Elena Roz, Carmelo Lupo, Giovanni Perconti, Agata Giallongo, Paola Migliorini, Antonio Marrazzo and Salvatore Feo. journal.pone. 2011 5(9):10.1371. (Product used TMA BR804). (link)
  48. Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer. Xiaoxin S Xu, Le Wang, Judith Abrams and Gan Wang. Journal of Hematology & Oncology. 2011 4(17):1756-8722. (Product used TMA BL208). (link)
  49. The type III transforming growth factor-B receptor inhibits proliferation, migration, and adhesion in human myeloma cells. Kathleen E. Lamberta, Huang Huangb, Karthikeyan Mythreyea and Gerard C. Blobec . Originally published as MBoC in Press. 2011 22(9):1463-1472. (Product used TMA BM482). (link)
  50. A Novel Translocation Breakpoint within the BPTF Gene Is Associated with a Pre-Malignant Phenotype. Yosef Buganim,Ido Goldstein,Doron Lipson,Michael Milyavsky,Sylvie Polak-Charcon,Corine Mardoukh,Hilla Solomon,Eyal Kalo,Shalom Madar,Marina Perelman, Roy Navon,Naomi Goldfinger,Iris Barshack,Zohar Yakhini and Varda Rotter. journal.pone. 2011 5(3):10.1371. (Product used TMA MC803, MC2081). (link)
  51. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Sudarshan Anand, Bharat K Majeti, Lisette M Acevedo, Eric A Murphy, Rajesh Mukthavaram,Lea Scheppke, Miller Huang, David J Shields, Jeffrey N Lindquist, Philip E Lapinski, Philip D King,Sara M Weis and David A Cheresh. Nature Medicine. 2011 16:909-914. (Product used TMA ). (link)
  52. PHOSPHORYLATION OF CASPASE-7 BY P21-ACTIVATED PROTEIN KINASE (PAK)2 INHIBITS CHEMOTHERAPEUTIC DRUGS-INDUCED APOPTOSIS OF BREAST CANCER CELL LINES . Xiang Li,Weihong Wen,Kangdong Liu,Feng Zhu,Margarita Malakhova,Cong Peng,Tingting Li,Hong-Gyum Kim,Weiya Ma,Yong Yeon ChoAnn M.Bode,Ziming Dong and Zigang Dong. The Journal of Biological Chemistry. 2011 286:22291-22299. (Product used TMA ). (link)
  53. Beta-Arrestin-1-Dependent Activation of Extracellular Signal-Regulated Kinases in RON Receptor-Mediated Tumorigenic Activities in Colon Cancer Cells. Yong-Qing Zhou,Yu-Lan Luo, Wendy Zhou, Hang-Ping Yao and Ming-Hai Wang. J.Cancer Mol. 2011 5:55-62. (Product used TMA ). (link)
  54. Differentiating Proteomic Biomarkers in Breast Cancer by Laser Capture Microdissection and MALDI MS. Melinda E. Sanders,Eduardo C. Dias,Baogang,James A. Moble,Dean Billheimer,Heinrich Roder,Julia Grigorieva,Mitchell Dowsett and Richard M. Caprioli. J Proteome Res. 2011 7(4):1500-7. (Product used TMA ). (link)
  55. Neurofilament Heavy Polypeptide Regulates the Akt-B-Catenin Pathway in Human Esophageal Squamous Cell Carcinoma. Myoung Sook Kim, Xiaofei Chang, Cynthia LeBron, Jatin K. Nagpal, Juna Lee, Yiping Huang, Keishi Yamashita, Barry Trink, Edward A. Ratovitski and David Sidransky. PLoS One. 2010 5(2):e9003. (Product used TMA ES801). (link)
  56. Induction of Np63 by the Newly Identified Keratinocyte-Specific Transforming Growth Factor B Signaling Pathway with Smad2 and I k B Kinase a in Squamous Cell Carcinoma1,2. Nahoko Fukunishi,Iyoko Katoh,Yoshiya Tomimor,Keiichi Tsukinoki,Ryu-Ichiro Hata,Atsuhito NakaoYoji Ikawa and Shun-ichi Kurata. Neoplasia. 2010 12(12):969-976. (Product used TMA OR802). (link)
  57. A Regulatory Mechanism for RSK2 NH 2 -Terminal Kinase Activity. Yong-Yeon Cho, Ke Yao, Angelo Pugliese, Margarita L. Malakhova, Ann M. Bode and Zigang Dong. Cancer Res . 2011 69(10):4398-4006. (Product used TMA SK801). (link)
  58. The Role of Breast Carcinoma Amplified Sequences 2 as a Transcription Cofactor of Androgen Receptor (AR) via AR Protein Stabilization . Ping-Chang Kuo adn Show-Li Chen . . 2011 :. (Product used TMA PR953). (link)
  59. Translational bioinformatics applications in genome medicine Atul J Butte. . Genome Medicine. 2009 1:64. (Product used TMA PA2081). (link)
  60. Type I Insulin-like Growth Factor Receptor Induces Pulmonary Tumorigenesis1. . Neoplasia. 2009 11(7):672-682. (Product used TMA LC1921). (link)
  61. The Guanine Nucleotide Exchange Factor SWAP-70 Modulates the Migration and Invasiveness of Human Malignant Glioma Cells1,2. Ho Jun Seol, Christian A. Smith, BodourSalhia and James T.Rutka. Translational Oncology. 2009 2(4):300-309. (Product used TMA GL803). (link)
  62. Aberrant Prothymosin-alpha Expression in Human Bladder Cancer . Y. Tsai, Y. Jou,G . Lee, Y. Chen, A. Shiau, H. Tsai, C.Wu, and T. Tzai. Urology. 2009 73(1):188-192. (Product used TMA BL241, BL801). (link)
  63. Aberrant Promoter Methylation of Sparc in Ovarian Cancer1,2 . Matthew J Socha, Neveen Said, Yanshan Dai, Joseph Kwong, Preetha Ramalingam, Vuong Trieu, Neil Desai, Samuel C Mok and Kouros Motamed. Neoplasia. 2009 11(2):126-135. (Product used TMA OV801, OV2001). (link)
  64. The mRNA Binding Proteins HuR and Tristetraprolin Regulate Cyclooxygenase 2 Expression During Colon Carcinogenesis. L. Young, S. Sanduja, K. Bemis Standoli, E. Pena, R. Price and D.Dixon. Gastroenterology. 2009 5:1669-1679. (Product used TMA CO801). (link)
  65. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway. Bin Li, Sai Wah Tsao, Yuk Yin Li, Xianghong Wang, Ming Tat Ling, Yong Chuan Wong, Qing Yu He and Annie L M Cheung . International Journal of Cancer. 2009 9999:. (Product used TMA ES802). (link)
  66. Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody. Cameron,Michael J. BSc, Rubin, Mark A. MD,Chang,Martin C.MD,PhD,Aster Jon C. MD, PhD, Haack, Herbert PhD, Johnson, Laura A.BSc, Fry, ChristopherJ. PhD Crosby, Katherine BSc,Polakiewicz, Roberto D. PhD, Stelow, Edward B. MD, Hong, Seung-Mo MD, PhD, French, Christopher A. MD,Schwartz and Brian E.PhD. . The American Journal of Surgical. 2009 33:984. (Product used TMA CO701). (link)
  67. A Regulatory Mechanism for RSK2 NH2-Terminal Kinase Activity. Yong-Yeon Cho, Ke Yao, Angelo Pugliese, Margarita L. Malakhova, Ann M. Bode and Zigang Dong . Cancer Research. 2009 69(10):4398-4406. (Product used TMA SK801). (link)
  68. Overexpression of Akt/PKB modulates N-myristoyltransferase activity in cancer cells. Anuraag Shrivastav, Shailly Varma, Arnie Senger, Ramji L Khandelwal, Svein Carlsen and Rajendra K Sharma . The Journal of Pathology. 2009 :. (Product used TMA BR802). (link)
  69. Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer. Takeo Fujita, Hirokuni Ikeda, Naruto Taira, Shinji Hatoh, Minoru Naito and Hiroyoshi Doihara. BMC Cancer . 2009 9:87. (Product used TMA ). (link)
  70. Overexpression and Mislocalization of the Chromosomal Segregation Protein Separase in Multiple Human Cancers. Rene Meyer, Viacheslav Fofanov, AnilK.Panigrahi, Fatima Merchant, Nenggang Zhang and Debananda Pati . Clinical Cancer Research. 2009 15:2703. (Product used TMA BS26011). (link)
  71. Novel Breast Cancer Metastasis-Associated Proteins. Jiapei Ho, Jacklyn-Wai-Fun Kong, Lee-Yee Choong, Marie-Chiew-Shia Loh, Weiyi Toy, Poh-Kuan Chong, Chee-Hong Wong, Chow-Yin Wong, Nilesh Shah and Yoon-Pin Lim. J.Proteome Res.. 2009 8 (2):583-594. (Product used TMA ). (link)
  72. Fibroblast Growth Factor Receptor 1 ansformed Mammary Epithelial Cells Are Dependent on RSK Activity for Growth and Survival. Wa Xian, Leontios Pappas, Darshan Pandya, Laura M. Selfors, Patrick W. Derksen, Michiel de Bruin,Nathanael S. Gray, Jos Jonkers, Jeffrey M. Rosen and Joan S. Brugge. Cancer Research. 2009 69:2244. (Product used TMA BR805, BR809). (link)
  73. Role of CCL11/eotaxin-1 signaling in ovarian cancer. Vera Levina, Brian M. Nolen, Adele M. Marrangoni, Peng Cheng, Jeffrey R. Marks, Miroslaw J. Szczepanski, Marta E. Szajnik, Elieser Gorelik and Anna E. Lokshin. Clin Cancer Res.. 2009 15:2647-2656. (Product used TMA ). (link)
  74. Cystatin B As a Tissue and Urinary Biomarker of Bladder Cancer Recurrence and Disease Progression. Adam S. Feldman, Jacqueline Banyard, Chin-Lee Wu, W. Scott McDougal and Bruce R. Zetter. Clinical Cancer Research. 2009 15:1024. (Product used TMA BL801). (link)
  75. IL15 Can Reverse the Unresponsiveness of Wilms'Tumor Antigen-Specific CTL in Patients with Prostate Cancer. Judy W. King, Sharyn Thomas, Fabrizio Corsi, Liquan Gao, Roberto Dina Roopinder Gillmore, Katharine Pigott, Amir Kaisary, Hans J. Stauss and Jonathan Waxman. Clinical Cancer Research. 2009 15:1145. (Product used TMA ). (link)
  76. AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001. Marin Marinov, Algirdas Ziogas, Olivier. Pardo, Liwen Terence Tan, Tony Dhillon, Francesco A. Mauri, Heidi A. Lane,Nicholas R. Lemoine, Uwe Zangemeister-Wittke, Michael J.Seckl and Alexandre Arcaro. Clinical Cancer Research. 2009 15:1277. (Product used TMA BN04011, BS04111). (link)
  77. Smad Ubiquitination Regulatory Factor 2 Promotes Metastasis of Breast Cancer Cells by Enhancing Migration and Invasiveness. Chaoyang Jin, Yu-an Yang, Miriam R. Anver, Nicole Morris, Xiangchun Wang and Ying E. Zhang. Cancer Research. 2009 69:735. (Product used TMA BR801). (link)
  78. Transient Receptor Potential Type Vanilloid 1 Suppresses Skin Carcinogenesis. Ann M. Bode, Yong-Yeon Cho, Duo Zheng, Feng Zhu, Marna E. Ericson, Wei-Ya Ma, Ke Yao and Zigang Dong. Cancer Research. 2009 69:905. (Product used TMA ). (link)
  79. Aberrant Promoter Methylation of Sparc in Ovarian Cancer. Matthew J. Socha, Neveen Said, Yanshan Dai, Joseph Kwong,Preetha Ramalingam,Vuong Trieu, Neil Desai, Samuel C. Mok and Kouros Motamed. NEOplasia. 2009 11(2):126-135. (Product used TMA OV801, OV2001). (link)
  80. cAMP response element-binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation. LINNERTH, N. M. GREENAWAY, J. B, PETRIK, J. MOOREHEAD, R. A.. International Journal of Gynecological Cancer. 2009 18(6):1248-1257. (Product used TMA ). (link)
  81. Aberrant Prothymosin-alpha Expression in Human Bladder Cancer. Yuh-Shyan Tsai, Yeong-Chin Jou, Gia-Fong Lee, Yeong-Chang Chen, Ai-Li Shiau, Hsin-Tzu Tsai, Chao-Liang Wu and Tzong-Shin Tzai. Basic and Translational Science. 2009 73(1):189-192. (Product used TMA BL241, BL801). (link)
  82. A genome-wide shRNA screen identifies GAS1 as a novel melanoma metastasis suppressor gene . Stephane Gobeil, Xiaochun Zhu, Charles J. Doillon and Michae R. Green. Cold Spring Harbor Laboratory Press . 2008 22:2932-2940 . (Product used TMA ). (link)
  83. SmgGDS Regulates Cell Proliferation, Migration and NF-B Transcriptional Activity in Non-small Cell Lung Carcinoma. Gaik Wei Tew1, Ellen L. Lorimer, Tracy J. Berg, Huiying Zhi, Rongshan Li and Carol L.Williams. The Journal of Biological Chemistry. 2008 283:963-976. (Product used TMA ). (link)
  84. Evaluation of CD133 expression in brain tumors using tissue array. Keiji Shimizu, Ayano Kumasawa, Shinichi Toyonaga, Takanori Masahira, Hiromochi Nakabayashi, Kaechang Park, Toshio Yawata Department Neurosurgery, Kochi Medical School and Kochi Japan. . 2008 :. (Product used TMA ). (link)
  85. SATB1 tethers multiple gene loci to reprogram expression profile driving breast cancer metastasis . Han,Hye-Jung, Kohwi, Yoshinori, Kohwi-Shigematsu and Terumi. Lawrence Berkeley National Laboratory. 2008 :. (Product used TMA ). (link)
  86. Genomic and Proteomic Profiles Reveal the Association of Gelsolin to TP Status and Bladder Cancer Progression. Marta Sanchez-Carbayo, Nicholas D. Socci and Lee Ric. american journal of pathology. 2008 28:12(22). (Product used TMA ). (link)
  87. Tissue array for Tp53, C-myc, CCND1 gene over-expression in different tumors. . WORLD JOURNAL OF GASTROENTEROLOGY. 2008 14:47. (Product used TMA ). (link)
  88. Nuclear Receptor Interaction Protein (NRIP) expression assay using human tissue microarray and immunohistochemistry technology confirming nuclear localization. Chih-Ping Han, Ming-Yung Lee, Shu-Ling Tzeng, Chung-Chin Yao, Po-Hui Wang, Ya-Wen Cheng, Show-Li Chen, Teresa S Wu, Yeu-Sheng Tyan and Lai-Fong Kok. J Exp Clin Cancer Res. 2008 27(1):25. (Product used TMA BCN962). (link)
  89. Transforming Growth Factor-(beta-1) Promotes Matrix Metalloproteinase-9-CMediated Oral Cancer Invasion through Snail Expression. Limin Sun, Michelle E. Diamond, Adam J. Ottaviano, Mathew J. Joseph, Vijayalakshmi Ananthanarayan and Hidayatullah G. Munshi. Mol Cancer Res. 2008 6:1. (Product used TMA ). (link)
  90. Regulatory effect of nerve growth factor in 9 integrin ependent progression of glioblastoma. Meghan C.Brown, Izabela Staniszewska, Philip Lazarovici, George P. Tuszynski, Luis Del Valle and Cezary Marcinkiewicz . Neuro Oncol . 2008 10(6):968-980. (Product used TMA ). (link)
  91. Nuclear Receptor Interaction Protein (NRIP) expression assay using human tissue microarray and immunohistochemistry technology confirming nuclear localization. Chih-Ping Han, Ming-Yung Lee, Shu-Ling Tzeng, Chung-Chin Yao, Po-Hui Wang, Ya-Wen Cheng, Show-Li Chen, Teresa S Wu, Yeu-Sheng Tyan and Lai-Fong Kok. J Exp Clin Cancer Res. 2008 27(1):25. (Product used TMA BCN962). (link)
  92. Transforming Growth Factor-B1 Promotes Matrix Metalloproteinase-9 Mediated Oral Cancer Invasion through Snail Expression. Limin Sun, Michelle E. Diamond, Adam J. Ottaviano, Mathew J. Joseph, Vijayalakshmi Ananthanarayan Hidayatullah G.Munshi. Mol Cancer Res. 2008 6(1):. (Product used TMA ). (link)
  93. Feedback Regulation between Zipcode Binding Protein 1 and Catenin mRNAs in Breast Cancer Cells. Wei Gu, Amber L. Wells, Feng Pan and Robert H. Singer. Molecular and Cellular Biology. 2008 28(16):4963-4974. (Product used TMA ). (link)
  94. Sox7 Is an Independent Checkpoint for beta-Catenin Function in Prostate and Colon Epithelial Cells. Lizheng Guo, Diansheng Zhong, Stephen Lau, Xiuju Liu, Xue-Yuan Dong, Xiaodong Sun, Vincent W. Yang, Paula M. Vertino, Carlos S. Moreno, Vijay Varma, Jin-Tang Dong and Wei Zhou. Cancer Genes and Genomics. 2008 6:1421-1430. (Product used TMA ). (link)
  95. Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival. Chun-Liang Chen, Ling Cen, Jennifer Kohout, Brian Hutzen, Christina Chan, Fu-Chuan Hsieh, Abbey Loy, Victor Huang, Gong Cheng and Jiayuh Lin. Molecular Cancer. 2008 7:78-89. (Product used TMA ). (link)
  96. Nuclear localization and intensity of staining of nm23 protein is useful marker for breast cancer progression. Nawfal I Ismail, Gurjeet Kaur, Hasnah Hashim Mohammed S Hassan. Cancer Cell Int. 2008 8:6. (Product used TMA BR1001, BR2001). (link)
  97. Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer. Kiwon Lee, Yin Liu, Jun Qin Mo, Jinsong Zhang, Zhongyun Dong and Shan Lu. BMC Cancer. 2008 8:158. (Product used TMA ). (link)
  98. Identification of interleukin-13 receptor a2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma. Bharat H. Joshi, Rada A. Puri, Pamela Leland, Frederick Varricchio, Ghanshyam Gupta, Mehmet Kocak, Richard J. Gilbertson Raj K. Puri,. Neuro-Oncology. 2008 10:265-274. (Product used TMA ). (link)
  99. Fluorophore-conjugated anti-CEA Antibody for the Intraoperative Imaging of Pancreatic and Colorectal Cancer. Sharmeela Kaushal, Michele K. McElroy, George A. Luiken, Mark A. Talamini, A. R. Moossa, Robert M. Hoffman and Michael Bouvet. Journal of Gastrointestinal Surgery. 2008 12:1938-1950. (Product used TMA ). (link)
  100. Dissection of the APCCdh1-Skp2 Cascade in Breast Cancer. Takeo Fujita, Weijun Liu, Hiroyoshi Doihara, Hiroshi Date and Yong Wan. Clinical Cancer Research. 2008 14:1966-1975. (Product used TMA ). (link)
  101. ssDNA-Binding Protein 2 Is Frequently Hypermethylated and Suppresses Cell Growth in Human Prostate Cancer. Jun-Wei Liu, Jatin K.Nagpal, Wenyue Sun and Juna Lee. Clinical Cancer Research. 2008 14:3754-3760. (Product used TMA ). (link)
  102. Monoclonal Antibody CC188 Binds a Carbohydrate Epitope Expressed on the Surface of Both Colorectal Cancer Stem Cells and their Differentiated Progeny. Mai Xu, Yuan Yuan, Yang Xia and Samuel Achilefu. Clinical Cancer Research. 2008 14:7461-7469. (Product used TMA ). (link)
  103. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation. Jian Teng, Zun-Yi Wang, David F Jarrard and Dale E Bjorling. Endocr Relat Cancer. 2008 15:351-364. (Product used TMA BC19111, PR801). (link)
  104. A genome-wide shRNA screen identifies GAS1 as a novel melanoma metastasis suppressor gene. Stephane Gobeil, Xiaochun Zhu, Charles J.Doillon Michael R.Green. Genes & Dev. 2008 22:2932-2940. (Product used TMA ME1001). (link)
  105. Identification of a Core Set of 58 Gene Transcripts With Broad and Specific Expression in the Microvasculature. Elisabet Wallgard, Erik Larsson, Liqun He, Mats Hellstrom, Annika Armulik, aya H. Nisancioglu, Guillem Genove, Per Lindahl, Christer Betsholtz . Arteriosclerosis,Thrombosis Vascular Biology. 2008 28:1469. (Product used TMA ). (link)
  106. CX3CR1 Is Expressed by Prostate Epithelial Cells and Androgens Regulate the Levels of CX3CL1/Fractalkine in the Bone Marrow: Potential Role in Prostate Cancer Bone Tropism. Whitney L. Jamieson, Saori Shimizu, Julia A. D'Ambrosio1, Olimpia Meucci1 and Alessandro Fatatis. Cancer Research. 2008 68:1715-1722. (Product used TMA ). (link)
  107. Cyclin-Dependent Kinase 3-Mediated Activating Transcription Factor 1 Phosphorylation Enhances Cell Transformation. Duo Zheng, Yong-Yeon Cho, Andy T. Y. Lau, Jishuai Zhang, Wei-Ya Ma, Ann M.Bode and Zigang Dong . Cancer Research. 2008 68:7650-7660. (Product used TMA ). (link)
  108. Suppressor role of activating transcription factor 2 (ATF2) in skin cancer. Anindita Bhoumik, Boris Fichtman, Charles DeRossi, Wolfgang Breitwieser, Harriet M. Kluger, Sean Davis, Antonio Subtil, Paul Meltzer, Stan Krajewski and Nic Jones Ze'ev Ronai. PNAS. 2008 105:1674-1679 . (Product used TMA ). (link)
  109. Regulation of Skp2-p27 Axis by the Cdh1/Anaphase-Promoting Complex Pathway in Colorectal Tumorigenesis. Takeo Fujita, Weijun Liu, Hiroyoshi Doihara and Yong Wan. American Journal of Pathology. 2008 173:217-228. (Product used TMA ). (link)
  110. Regulatory effect of nerve growth factor in {alpha}9beta1 integrin-dependent progression of glioblastoma. Meghan C. Brown, Izabela Staniszewska, Philip Lazarovici, George P. Tuszynski, Luis Del Valle and Cezary Marcinkiewicz . Neuro Oncol. 2008 10(6):968-980. (Product used TMA ). (link)
  111. Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression . Kristina E. Hoot, Jessyka Lighthall, Gangwen Han, Shi-Long Lu, Allen Li, Wenjun Ju, Molly Kulesz-Martin, Erwin Bottinger and Xiao-Jing Wang. J.Clin.Invest. 2008 118(8):2722-2732. (Product used TMA ). (link)
  112. Calcification of Multipotent Prostate Tumor Endothelium . Andrew C.Dudley, Zia A.Khan, Shou-Ching Shih, Soo-Young Kang, Bernadette M. M. Zwaans, Joyce Bischoff and Michael Klagsbrun. Cancer Cell. 2008 14(3):201-211. (Product used TMA ). (link)
  113. Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice. R. Wang, K. Sengupta, C. Li, H. Kim, L. Cao, C. Xiao, S.Kim, X.Xu, Y.Zheng and B.Chilton. Cancer Cell. 2008 14(4):312 - 323. (Product used TMA ). (link)
  114. The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development . Tyson V. Sharpa, Ahmad Al-Attarb, Daniel E. Foxlera, Li Dingc, Thomas Q. de A. Vallima, Yining Zhanga, Hala S. Nijmeha, Thomas M. Webba, Andrew G. Nicholsond, Qunyuan Zhange, Aldi Krajae, Ian Spendloveb, John Osbornec, Elaine Mardisc and Gregory D. Longmoref . PANS. 2008 15(50):9932-19937. (Product used ). (link)
  115. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation. Meissner, M. Whiteside, T. L. van Kuik-Romein, P. Valesky, E. M. van den Elsen, P. J. Kaufmann and R. Seliger. British Journal of Dermatology. 2008 158(5):930-940. (Product used TMA ). (link)
  116. Overexpression of the [alpha]v[beta]6 Integrin in Endometrial Cancer. Hecht Jonathan L. MD PhD, Dolinski Brian M., Gardner Humphrey A.MD, Violette Shelia M. PhD and Weinreb Paul H. PhD . Applied Immunohistochemistry & Molecular Morphology. 2008 16(6):543-547. (Product used TMA ). (link)
  117. Dickkopf-3 as a new potential marker for neoangiogenesis in colorectal cancer: Expression in cancer tissue and adjacent non-cancerous tissue. Matthias Zitt, Gerold Untergasser and Albert Amberger. Disease Markers. 2008 24(2):101-109. (Product used TMA ). (link)
  118. Hedgehog Signaling Regulates Brain Tumor Initiating Cell Proliferation and Portends Shorter Survival for Patients with PTEN-Coexpressing Glioblastomas . Qijin Xu, Xiangpeng Yuan, Gentao Liu, Keith L. Black and John S Yu. Stem Cells. 2008 26(12):3018-3026. (Product used TMA ). (link)
  119. SmgGDS Regulates Cell Proliferation, Migration, and NF-kappa B Transcriptional Activity in Non-small Cell Lung Carcinoma. Gaik Wei Tew, Ellen L. Lorimer, Tracy J. Berg, Huiying Zhi, Rongshan Li and Carol L. Williams. J.Biol.Chem. 2008 283(2):963-976. (Product used TMA ). (link)
  120. Regulation of 3-Phosphoinositide-dependent Protein Kinase-1 (PDK1) by Src Involves Tyrosine Phosphorylation of PDK1 and Src Homology 2 Domain Binding. Keum-Jin Yang, Sanghee Shin, Longzhen Piao, Eulsoon Shin, Yuwen Li, Kyeong Ah Park, Hee Sun Byun, Minho Won, Janghee Hong, Gi Ryang Kweon, Gang Min Hur, Jeong Ho Seok, Taehoon Chun, Derek P. Brazil, Brian A. Hemmings and Jongsun Park. J. Biol. Chem. 2008 283(3):1480-1491. (Product used TMA ). (link)
  121. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism . Yong-Hun Lee, Allan R. Albig, MaryAnn Regner, Barbara J. Schiemann and William P. Schiemann . Carcinogenesis. 2008 29(12):2243-2251. (Product used TMA BR241). (link)
  122. In Virto and In Vivo Photosensitizing Applications of Photofrin in Malignant Melanoma Cells. Cheng-Jen Chang, Jau-Song Yu and Fu-Chan Wei. Chang Guang Med J. 2008 31(3):260-267. (Product used TMA ). (link)
  123. Immunohistochemical determination of the P15INK4b protein expression in cutaneous squamous cell carcinoma. Ahmed I. Moad, Tan Mei Lan, Gurjeet Kaur, Hasnah Hashim, Mohamed J. E. M. F. Mabruk . Journal of Cutaneous Pathology. 2008 36(2):183-189. (Product used TMA ). (link)
  124. Endo180 expression with cofunctional partners MT1-MMP and uPAR-uPA is correlated with prostate cancer progression. Giolanta Kogianni, Marjorie M. Walker, Jonathan Waxman and Justin Sturge. European Journal of Cancer. 2008 45(4):685-693. (Product used TMA PR951, PR952). (link)
  125. Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers. Skliris G P,Hube F,Gheorghiu I,Mutawe M M,Penner C,Watson P H,Murphy L C,Leygue E,and Myal Y. Histopathology. 2008 52(3):355-369. (Product used TMA ). (link)
  126. Expression and sub-cellular localization of the CCAAT/enhancer binding protein in relation to postnatal development and malignancy of the prostate. Juan Zhang, John Erby Wilkinson, Mesfin Gonit, Rick Keck, Steven Selman, Manohar Ratnam . The Prostate. 2008 68(11):1206-1214. (Product used TMA PR802, PR952, BC19111). (link)
  127. S100A4 overexpression proves to be independent marker for breast cancer progression. Nawfal I Ismail, Gurjeet Kaur, Hasnah Hashim and Mohammed S Hassan. Cancer Cell International. 2008 8(12):1475-2867. (Product used TMA BR2001). (link)
  128. BK Virus as a Cofactor in the Etiology of Prostate Cancer in Its Early Stages. Dweepanita Das, Kirk Wojno and Michael J. Imperiale. J of Virology. 2008 82(6):2705-2714. (Product used TMA ). (link)
  129. Current Topics in Human Genetics: Studies in Complex Diseases. Hong-Wen Deng, Hui Shen, Yong-Jun Liu. World Scientific. 2008 :475. (Product used TMA ). (link)
  130. Decreased Plakophilin-1 Expression Promotes Increased Motility in Head and Neck Squamous Cell Carcinoma Cells. Tammy and James K. Wahl .ect. Cell Communication and Adhesion. 2007 2(3): 99-109. (Product used TMA ). (link)
  131. Expression of matrix metalloproteinases (MMP1, 2, 9, and 11) in metastatic lymph node tissue of breast cancer patients. . A. Fink-Retter, D. Gschwantler-Kaulich, G. Hudelist, I. Walter, K. Czerwenka and C.Singer . Journal of Clinical Oncology. 2007 1(25):. (Product used TMA ). (link)
  132. Increased Expression of the Collagen Internalization Receptor uPARAP/Endo180 in the Stroma of Head and Neck Cancer. Jay Sulek, Rebecca A. Wagenaar-Miller, Jessica Shireman, Alfredo Molinolo, Daniel H.Madsen, Lars H. Engelholm,Niels Behrendt and Thomas H.Bugge . Journal of Histochemistry and Cytochemistry. 2007 55 (4):347-353 . (Product used TMA ). (link)
  133. Mammaglobin vs GCDFP-15: An Immunohistologic Validation Survey: Materials and Methods. Rohit Bhargava, MD, Sushi Beriwal, MD and David J.Dabbs. American Journal of Clinical Pathology. 2007 127(1):103-113. (Product used TMA ). (link)
  134. A novel tissue array technique for high-throughput tissue microarray analysis microarray groups . Hui-Yong Jiang, Xue-Feng Zhang, Li Liu, Hui-Ling Li and Tong Zhao. In Vitro Cellular & Developmental Biology - Animal. 2007 43(3):109-112. (Product used TMA ). (link)
  135. BKV as a Cofactor in the Etiology of Prostate Cancer in its Early Stages. Dweepanita Das, Kirk Wojno and Michael J. Imperiale. J.Virol. 2007 :. (Product used TMA ). (link)
  136. A Suppressive Role of the Prolyl Isomerase Pin1 in Cellular Apoptosis Mediated by the Death-associated Protein Daxx . Akihide Ryo, Akiko Hirai, Mayuko Nishi, Yih-Cherng Liou, Kilian Perrem, Sheng-Cai Lin, Hisashi Hirano, Sam W.Lee and Ichiro Aoki. THE JOURNAL OF BIOLOGICAL CHEMISTRY. 2007 282(50):36671-36681. (Product used TMA ). (link)
  137. Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays. T Harada, C Chelala, V Bhakta, T Chaplin, K Caulee, P Baril, BD Young and NR Lemoine. Oncogene (online publication). 2007 1:1951-1960. (Product used TMA PA801). (link)
  138. Increased Expression of the Collagen Internalization Receptor uPARAP/Endo180 in the Stroma of Head and Neck Cancer. Jay Sulek, Rebecca A.,et all. J Histochem Cytochem. 2007 55:347-453. (Product used TMA ). (link)
  139. Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts. Alice P. Taylor and David M. Goldenberg. Molecular Cancer Therapeutics. 2007 6:524-531. (Product used TMA ). (link)
  140. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. Rosalyn D Blumenthal, et al. BMC Cancer. 2007 7:2. (Product used TMA BR1001, CO991 and LC801). (link)
  141. The Ubiquitin-Conjugating Enzyme E2-EPF Is Overexpressed in Primary Breast Cancer and Modulates Sensitivity to Topoisomerase II Inhibition. Donato Tedesco,et el. Neoplasia. 2007 9:601-613. (Product used TMA BR701). (link)
  142. Smad3 Is Overexpressed in Advanced Human Prostate Cancer and Necessary for Progressive Growth of Prostate Cancer Cells in Nude Mice. Shan Lu, Juwon Lee, Monica Revelo, Xiaohong Wang, Shan Lu and Zhongyun Dong. Clinical Cancer Research. 2007 13:5692-5702. (Product used TMA ). (link)
  143. Selective Down-Regulation of Glioma-Associated Oncogene 2 Inhibits the Proliferation of Hepatocellular Carcinoma Cells. Youngsoo Kim, Joon Won Yoon, Xiaokun Xiao, Nicholas M.Dean, Brett P. Monia and Eric G. Marcusson . Cancer Research. 2007 67:3583-3593. (Product used TMA ). (link)
  144. Tumor Necrosis Factor Receptor 1/c-Jun-NH2-Kinase Signaling Promotes Human Neoplasia. Jennifer Y. Zhang, Amy E.Adams, Todd W. Ridky, Shiying Tao and Paul A. Khavari . Cancer Research. 2007 67:3827-3834. (Product used FFPE Sections ). (link)
  145. AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts. Jing Zhang, et al. J.Clin.Invest. 2007 117:2962-2973. (Product used TMA BC19111). (link)
  146. A novel biomarker for the detection of esophageal adenocarcinoma. Zane T.Hammoud, et al. J Thorac Cardiovasc Surg. 2007 133:82-87. (Product used TMA ). (link)
  147. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Michael E. Hudson, Irina Pozdnyakova, et al. PANS. 2007 104 (44):17494-17499. (Product used TMA OR601). (link)
  148. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Zhenhua Miao, et al. PNAS. 2007 104(40):15735-15740. (Product used TMA ). (link)
  149. Overexpressed Raf-1 and phosphorylated cyclic adenosine 3-5-monophosphatate response element-binding protein are early markers for lung adenocarcinoma. Maria Cekanova, et al. Cancer. 2007 109(6):1164-1173. (Product used TMA LC1002). (link)
  150. Quantitative hypermethylation of NMDAR2B in human gastric cancer. Jun-Wei Liu, et al. International Journal of Cancer. 2007 121(9):1994-2000. (Product used TMA ). (link)
  151. Mammaglobin vs GCDFP-15: An Immunohistologic Validation Survey for Sensitivity and Specificity. Rohit Bhargava, et al. Am J Clin Pathol. 2007 127(1):103-113. (Product used TMA ). (link)
  152. Dickkopf-3 is expressed in a subset of adult human pancreatic beta cells. H.Hermman, et al. Histochemistry and Cell Biology. 2007 127(5):513-521. (Product used Tissue section ). (link)
  153. Haplotypes,Loss of Heterozygosity,and Expression Levels of Glycine N-Methyltransferase in Prostate Cancer. Yu-Chuen Huang, Cheng-Ming Lee, Marcelo Chen, Ming-Yi Chung, Yen-Hwa Chang, William Ji-Shian Huang, Donald Ming-Tak Ho, Chin-Chen Pan, Tony T. Wu, Stone Yang, Ming-Wei Lin, Jer-Tsong Hsieh and Yi-Ming Arthur Chen. Clinical Cancer Research. 2007 13(5):1412-1420. (Product used TMA ). (link)
  154. Association of Nuclear, Cytoplasmic Expression of Galectin-3 With beta-Catenin/Wnt-Pathway Activation in Thyroid Carcinoma. Paul M. Weinberger, MD, Bao-Ling Adam,PhD, Christine G. Gourin, MD, William H. Moretz III, MD, Roni J. Bollag, MD, PhD, Beverly Y. Wang, MD, Zhongmin Liu, PhD, Jeffrey R. Lee, MD, David J.Terris. Arch Otolaryngol Head Neck Surg. 2007 133(5):503-510. (Product used TMA TH802). (link)
  155. Expression of matrix metalloproteinases (MMP1, 2, 9, and 11) in metastatic lymph node tissue of breast cancer patients. A.Fink-Retter,et al. Journal of Clinical Oncology. 2007 25 (8S):21138. (Product used TMA BR1001). (link)
  156. Lobular Versus Ductal Breast Neoplasms: The Diagnostic Utility of P120 Catenin. Dabbs, David J., Bhargava, Rohit, Chivukula and Mamatha . American Journal of Surgical Pathology. 2007 31(3):427-437. (Product used TMA ). (link)
  157. Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue (Abstract). Christoph Zenzmaier, Gerold Untergasser, Martin Hermann, Stephan Dirnhofer, Natalie Sampson and Peter Berge. The Prostate (Wiley-Liss, Inc., A Wiley Company). 2007 68(5):540 - 547. (Product used TMA PR802). (link)
  158. The human papillomavirus type 16 E7 oncoprotein activates the Fanconi Anemia (FA) pathway and causes accelerated chromosomal instability in FA cells. Nicole Spardy, Anette Duensing, Domonique Charles, et al. J.Virol. 2007 81 (23):13265-13270. (Product used TMA CR801). (link)
  159. A Role for the G12 Family of Heterotrimeric G Proteins in Prostate Cancer Invasion*. Patrick Kelly, Laura N. Stemmle, John F .Madden, Timothy A. Fields, Yehia Daaka and Patrick J.Casey. THE JOURNAL OF BIOLOGICAL CHEMISTRY. 2006 281(36): 26483-26490. (Product used TMA ). (link)
  160. The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis. Patrick Kelly, Benjamin J, Moeller, Juhi Juneja, Michelle A.Booden, Channing J.Der, Yehia Daaka, Mark W.Dewhirst, Timothy A.Fields and Patrick J.Casey. PNAS. 2006 21(103):8173-8178 . (Product used TMA ). (link)
  161. Vav3 Oncogene Is Overexpressed and Regulates Cell Growth and Androgen Receptor Activity in Human Prostate Cancer . Zhongyun Dong, Yin Liu, Shan Lu, Amy Wang, Kiwon Lee, Lu-Hai Wang, Monica Revelo and Shan Lu . Molecular Endocrinology. 2006 20 (10) :2315-2325. (Product used TMA ). (link)
  162. Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells. Philip L. Lorenzi, et al. Mol Cancer Ther. 2006 5:2613-2623. (Product used TMA OV2001). (link)
  163. Association of insulin-like growth factor binding protein-3 expression with melanoma progression. Yaguang Xi, et al. Mol Cancer Ther . 2006 5:3078-3084. (Product used TMA ). (link)
  164. Molecular Profiling of ADAM12 in Human Bladder Cancer. Camilla Frohlich, et al. Clinical Cancer Research . 2006 12:7359-7368. (Product used TMA BC12011, BL801 and BC12012). (link)
  165. CYP2A13 in Human Respiratory Tissues and Lung Cancers: An Immunohistochemical Study with A New Peptide-Specific Antibody. Liang-Ru Zhu, et all. Drug Metabolism and Disposition. 2006 34:1672-1676. (Product used Tissue section HuFPT111 and 131). (link)
  166. A role for the G12 family of heterotrimeric G-proteins in prostate cancer invasion. Patrick Kelly,Laura N.Stemmle,et al. J.Biol.Chem. 2006 36:26483-26490. (Product used TMA BR801). (link)
  167. Increased Levels of the FoxM1 Transcription Factor Accelerate Development and Progression of Prostate Carcinomas in both TRAMP and LADY Transgenic Mice. Tanya V.Kalin, et al. Cancer Research . 2006 66:1712-1720. (Product used TMA ). (link)
  168. The Forkhead Box m1 Transcription Factor Stimulates the Proliferation of Tumor Cells during Development of Lung Cancer. Il-Man Kim,et al. Cancer Research . 2006 66:2153-2161. (Product used TMA LC1001). (link)
  169. Tyrosine Kinase Etk/BMX Is Up-regulated in Human Prostate Cancer and Its Overexpression Induces Prostate Intraepithelial Neoplasia in Mouse. Bojie Dai, et al. Cancer Research. 2006 66:8058-8064. (Product used TMA BC19111, PR801 and PR802). (link)
  170. The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis Patrick Kelly, et al. Patrick Kelly, Laura N. Stemmle, et al. PNAS. 2006 103(21):8173-8178. (Product used TMA BR801). (link)
  171. A critical role for Ikappa B kinase alpha in the development of human and mouse squamous cell carcinomas. Bigang Liu, et all. Proc Natl Acad Sci USA. 2006 103(46):17202-17207. (Product used TMA SK801, SK802). (link)
  172. Isoform-specific regulation of UDP-glucuronosyltransferase (UGT)2B enzymes in the human prostate: differential consequences for androgen and bioactive lipid inactivation. Sarah Chouinard, et al. Endocrinology. 2006 147(11):5431-5442. (Product used TMA ). (link)
  173. Vav3 Oncogene Is Overexpressed and Regulates Cell Growth and Androgen Receptor Activity in Human Prostate Cancer. Zhongyun Dong, et al. Molecular Endocrinology . 2006 20(10):2315-2325. (Product used TMA PR801, PR802). (link)
  174. WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Lynne Bingle, et al. Respiratory Research . 2006 7(1):61. (Product used TMA LC801). (link)
  175. Secretagogin is a Novel Marker for Neuroendocrine Differentiation. Karin Birkenkamp-Demtroder,et al. Neuroendocrinology. 2005 82:121-138. (Product used TMA EN801). (link)

Tissue microarray technology:

  1. Holger Moch, Juha Kononen, Olli-P. Kallioniemi, and Guido Sauter, Tissue microarrays: what will they bring to molecular and anatomic pathology. Advances in Anatomic Pathology Vol.8, No.1,14-20, (2001).
  2. Ronald Simon, Jan Richter, Urs Wagner, et al., High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res. 61:4514-4519, (2001).
  3. Mark A. Rubin. Use of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate Cancer. J. Pathol. 195:80-86, (2001).
  4. Olli-P. Kallioniemi, Urs Wagner, Juha Kononen and Guido Sauter, Tissue microarray technology for high-throughput molecular profiling of cancer. Human Molecular Genetics Vol.10, No.7, 657-662, (2001).
  5. David L. Rimm, Robert L. Camp, Lori A.Charette, et al., Tissue microarray: a new technology for amplification of tissue resources. The Cancer Journal Vol.7, No.1, (2001).
  6. Lukas Bubendorf, Antonio Nocito, Holger Moch and Guido Sauter, Tissue microarray (TMA) technology: miniaturized pathology archives for high -Throughput in situ studies. J. Pathol. 195:72-79, (2001).
  7. Chad R. Englert, Galina V. Baibakov, and Michael R. Emmert-Buck, Cancer Res. 60:1526-1530, (2000).
  8. F. von Eggeling, H. Davies, L. Lomas, W. Fiedler, K. Junker, U. Claussen and G. Ernst, Tissue-specific microdissection coupled with proteinchip array technologies: applications in cancer research. Biotechniques Vol.29, No.5, 1066-1070, (2000).
  9. Olivier Braissant and Walter Wahli, A simplified in situ hybridization protocol using non-radioactively labeled probes to detect abundant and rare mRNAs on tissue sections. Biochemica No.1, 10-16, (1998).
© 2003 - 2013 US Biomax Inc.   custsrv@biomax.us   Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal